Italy· 013013040
DISIPAL*50 cpr rivestite 50 mg
A orphenadrin, kombinationen product containing orfenadrina, registered in Italy by ECUPHARMA Srl, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Orphenadrin, kombinationen is registered in 4 of 19 countries.
Countries holding a registration under ATC M03BC51 (orphenadrin, kombinationen), each read from that country’s own register.
- This record: Italy
- 4 of them publish a price we can compare per daily dose
Orphenadrin, kombinationen · ATC M03BC51
4 / 19 countries
- Czechiaprice
- Finlandprice
- Icelandprice
- Italyprice
The record
At a glance
- Active substance
- Orfenadrina
- Manufacturer
- ECUPHARMA Srl
- Country
- Italy (IT)
- ATC code
- M03BC51
- ATC class
- Orphenadrin, Kombinationen
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic013013040DISIPAL*50 cpr rivestite 50 mgEUR 4.91
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Orphenadrin, kombinationen in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBiorphen 25mg/5ml oral solutionRosemont Pharmaceuticals Ltd
- United StatesOrphenadrine citrateHikma Pharmaceuticals USA Inc.
- FinlandNorflexParanova Oy
- GermanyNorflexViatris Healthcare Gmbh
- NorwayDisipalAstellas Pharma AS
- CanadaSANDOZ ORPHENADRINESANDOZ CANADA INCORPORATED
- SwedenNorflex 100 mg DepottablettViatris AB
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Norflex, Norflex N
- Denmark · Lysantin
- Finland · Norflex
- United Kingdom (Northern Ireland) · Orphenadrine Hydrochloride Rosemont Pharmaceuticals
- Greece · Orphedrin
- Sweden · Norflex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/59d1d014-8d77-4f2c-a4b2-c759509c2e52 GET /v1/drugs/59d1d014-8d77-4f2c-a4b2-c759509c2e52?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 4.91,
"source": "aifa",
"currency": "EUR",
"strength": "ORFENADRINA 50MG 50 UNITA' USO ORALE",
"substance": "Orfenadrina",
"equivalence_group": "PQA",
"transparency_flag": null
}See everything about orphenadrin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.